Company Profile

OGB5 Inc
Profile last edited on: 2/3/26      CAGE: 9MFF4      UEI: RG67R8RMV1U5

Business Identifier: Non-viral nanoparticle gene therapy delivery
Year Founded
----
First Award
2024
Latest Award
2024
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

201 E 5th Street Suite 2505
Cincinnati, OH 45206
   N/A
   N/A
   www.orangegrovebio.com
Location: Single
Congr. District: 01
County: Hamilton

Public Profile

OGB5, Inc. is an Ohio-based, domestic for-profit federal contractor and grant recipient specializing in R&D in the biotechnology arena. Company has secured federal funding for projects related to non-viral nanoparticle gene therapy delivery. Focus Areas: R&D--with recent work focusing on gene therapy delivery systems. Entity Type: Registered as a federal contractor in SAM.gov and a recipient of federal grant awards. Recent Funding: National Institutes of Health (NIH/NHLBI) SBIR support for a, non-viral nanoparticle gene therapy delivery project.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Colin T Sheehan

Company News

There are no news available.